PTV | Dosimetric parameters | VMAT | Helical Tomotherapy | P |
---|---|---|---|---|
PTV 63 | D2% (Gy) | 65.4 (64.2-67.0) | 64.9 (64.1-66.0) | 0.131 |
 | D50% (Gy) | 63 (63.0-63.9) | 62.9 (62.8-63.1) | 0.062 |
 | D98% (Gy) | 58.4 (57.4-60.7) | 59.3 (57.0-60.7) | 0.248 |
 | TCov-I | 0.94 (0.90-0.99) | 0.96 (0.91-0.99) | 0.091 |
 | HTConf-I | 0.85 (0.77-0.92) | 0.77 (0.66-0.94) | 0.016* |
 | CN | 0.78 (0.76-0.87) | 0.74 (0.62-0.85) | 0.033* |
 | DSC | 0.88 (0.87-0.93) | 0.85 (0.77-0.92) | 0.033* |
 | HI | 0.11 (0.06-0.15) | 0.09 (0.05-0.13) | 0.109 |
PTV 54 | D2% (Gy) | 64.9 (56.3-66.4) | 64.3 (55.0-65.7) | 0.109 |
 | D50% (Gy) | 57.5 (54.0-62.3) | 57.1 (54.0-61.9) | 0.168 |
 | D98% (Gy) | 51.0 (48.6-52.0) | 51.8 (50.5-53.6) | 0.016* |
 | TCov-I | 0.97 (0.90-0.99) | 0.99 (0.97-1.00) | 0.008* |
 | HTConf-I | 0.84 (0.71-0.89) | 0.63 (0.51-0.69) | 0.003* |
 | CN | 0.76 (0.69-0.82) | 0.62 (0.50-0.67) | 0.003* |
 | DSC | 0.86 (0.78-0.90) | 0.77 (0.67-0.81) | 0.003* |
 | HI | 0.25 (0.12-0.29) | 0.22 (0.06-0.26) | 0.016* |